News from angiotech pharmaceuticals, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jun 22, 2015, 08:00 ET Surgical Specialties Corporation Announces Medicare Approval of Transitional Pass-Through Reimbursement for BioSentry™ Track Sealant System

CMS Decision Provides Supplemental Reimbursement to U.S. Hospitals for New Medical Device with Potential to Improve Outcomes for Patients Undergoing...

Mar 09, 2015, 01:33 ET Surgical Specialties Corporation Awarded Three Year Suture Products Agreement with Premier, Inc.

BRAINTREE, MA, March 9, 2015 /PRNewswire/ - Surgical Specialties Corporation, a leading provider of branded, private label , and OEM medical devices...

Feb 23, 2015, 03:00 ET Angiotech announces K. Thomas Bailey departure from Board of Directors

BRAINTREE, MA, Feb. 23, 2015 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. announced today that K. Thomas Bailey has stepped down from the company's ...

Dec 02, 2014, 03:54 ET Surgical Specialties Announces Leadership Team Additions

BRAINTREE, MA and VANCOUVER, BC, Dec. 2, 2014 /PRNewswire/ - Surgical Specialties, Inc. announced today two important additions to its executive...

Oct 09, 2014, 08:00 ET Angiotech Appoints John Barr as CEO

VANCOUVER, Oct. 9, 2014 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. announced today that its Board of Directors has appointed John R. Barr as...

Mar 21, 2014, 01:00 ET Angiotech Pharmaceuticals, Inc. announces 2013 financial results and provides update on recent developments

VANCOUVER, March 21, 2014 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. ("ANPI") today announced its financial results for the quarter and year...

Oct 11, 2013, 09:00 ET Angiotech Announces Changes to Management and Board of Directors

VANCOUVER, Oct. 11, 2013 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. ("Angiotech") announced today that its shareholders and Board of Directors...

Jul 25, 2013, 11:33 ET Angiotech Announces Conference Call and Webcast of Second Quarter 2013 Results

Private Call and Webcast Available Only to Shareholders of Record VANCOUVER, July 25, 2013 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. will host a ...

May 31, 2013, 08:00 ET Angiotech announces return of capital to common shareholders

VANCOUVER, May 31, 2013 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. ("Angiotech") announced today that a return of capital will be provided to all ...

Apr 15, 2013, 08:01 ET Angiotech announces redemption of its Senior Floating Rate Notes due 2013 and of Angiotech Pharmaceuticals (US), Inc.'s Senior 9% Notes due 2016

VANCOUVER, April 15, 2013 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. ("Angiotech") announced that on April 12, 2013, Deutsche Bank National Trust ...

Apr 15, 2013, 08:00 ET Angiotech announces close of sale of Interventional Products Business to Argon Medical Devices, Inc.

VANCOUVER, April 15, 2013 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. ("Angiotech") announced today that on April 12, 2013 it completed its...

Mar 28, 2013, 05:30 ET Angiotech Announces Financial Results for the Fourth Quarter Ended December 31, 2012

VANCOUVER, March 28, 2013 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. ("Angiotech") announced that it released its financial results for the...

Mar 25, 2013, 08:00 ET Angiotech announces sale of Interventional Products Business to Argon Medical Devices, Inc.

VANCOUVER, March 25, 2013 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. ("Angiotech") announced today that it had entered into a definitive...

Mar 18, 2013, 05:12 ET Angiotech Pharmaceuticals announces Conference Call and Webcast - Fourth Quarter and Year End 2012 Financial Results

VANCOUVER, March 18, 2013 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. will host a conference call discussing its financial results for the fourth...

Mar 18, 2013, 02:13 ET Angiotech announces redemption of portion of Senior Floating Rate Notes due 2013

VANCOUVER, March 18, 2013 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. ("Angiotech") announced that today, Deutsche Bank National Trust Company...

Dec 20, 2012, 02:28 ET Angiotech Receives FDA Approval for its Proprietary Bio-Seal™ Lung Biopsy Device

VANCOUVER, Dec. 20, 2012 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. ("Angiotech") announced today that it received approval on December 19, 2012...

Nov 16, 2012, 05:31 ET Angiotech partner Cook Medical receives FDA approval for its Zilver PTX Paclitaxel-eluting peripheral stent

VANCOUVER, Nov. 16, 2012 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. ("Angiotech") announced that its partner Cook Medical, Inc. ("Cook") received ...

Nov 14, 2012, 08:00 ET Angiotech Announces Financial Results for the Third Quarter Ended September 30, 2012

VANCOUVER, Nov. 14, 2012 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. ("Angiotech") announced that it released its financial results for the third...

Nov 01, 2012, 03:00 ET Angiotech Pharmaceuticals Announces Conference Call and Webcast

Third Quarter 2012 Financial Results VANCOUVER, Nov. 1, 2012 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. will host a conference call discussing...

Sep 18, 2012, 01:30 ET Angiotech announces redemption of portion of Senior Floating Rate Notes due 2013

VANCOUVER, Sept. 18, 2012 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. ("Angiotech") announced that on September 17, 2012, Deutsche Bank National...

Aug 14, 2012, 06:30 ET Angiotech Announces Financial Results for the Second Quarter Ended June 30, 2012

VANCOUVER, Aug. 14, 2012 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. ("Angiotech") announced that it released its financial results for the second ...

Aug 10, 2012, 08:30 ET Angiotech Pharmaceuticals, Inc. Announces Expiration of Exchange Offer for up to $225,000,000 of its Senior Floating Rate Notes Due 2013

VANCOUVER, Aug. 10, 2012 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. ("Angiotech") announced today the expiration of the offer by its subsidiary,...

Aug 01, 2012, 04:00 ET Angiotech Pharmaceuticals Announces Conference Call And Webcast

Second Quarter 2012 Financial Results VANCOUVER, Aug. 1, 2012 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. will host a conference call discussing...

Jul 27, 2012, 05:00 ET Angiotech Pharmaceuticals, Inc. Amends Exchange Offer and Consent Solicitation for its Senior Floating Rate Notes Due 2013

Increased Maximum Exchange Offer Size: $225 Million Updated Expiration Time: 11:59 P.m., New York City Time, August 9, 2012 VANCOUVER, July 27, 2012...

Jul 03, 2012, 04:46 ET Angiotech Pharmaceuticals, Inc. Launches Exchange Offer and Consent Solicitation for up to $200,000,000 of its Senior Floating Rate Notes Due 2013

VANCOUVER, July 3, 2012 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. ("Angiotech") announced today that it has commenced an offer to exchange (the...